Company news
Phibro Animal Health Corporation (NASDAQ:PAHC) news
Phibro Animal Health Corporation news releases on 6ix. Latest, Sep 9, 2026: Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global…
Press releases & updates
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
September 9, 2026
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results
August 19, 2026
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference
May 21, 2026
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference
May 7, 2026
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership
May 6, 2026
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership
May 5, 2026
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials
April 26, 2026
Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit
February 18, 2026
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
February 3, 2026
Phibro Animal Health Corporation Declares Quarterly Dividend
February 2, 2026
Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
January 28, 2026
Phibro Animal Health Corporation Announces Leadership Transition
December 17, 2025
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
November 4, 2025
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
October 29, 2025
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
October 28, 2025
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs
October 8, 2025
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
September 1, 2025
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
August 26, 2025
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
August 19, 2025
Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference
May 21, 2025
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance
May 6, 2025
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
April 22, 2025
Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference
March 4, 2025
Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit
February 19, 2025
Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors
January 22, 2025
Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products
October 30, 2024
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results
August 13, 2024
Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability
June 4, 2024
Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference
May 19, 2024
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
April 27, 2024
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
February 28, 2024
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit
February 13, 2024
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
February 5, 2024
Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers
November 6, 2023
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results
July 30, 2023
Phibro Issues Second Environmental, Social and Governance Report
May 7, 2023
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results
May 2, 2023
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results
April 12, 2023
Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.
April 4, 2023
Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit
February 13, 2023
Phibro Animal Health Corporation Reports Second Quarter Results
February 7, 2023
Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend
February 5, 2023
Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results
January 8, 2023
Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance
November 8, 2022
Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial Results
October 2, 2022
Phibro Animal Health Corporation to Participate in Morgan Stanley Global Healthcare Conference
August 14, 2022
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 Results
July 26, 2022
Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines
June 21, 2022
Phibro Issues Inaugural Environmental, Social and Governance Report
June 8, 2022
Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance
May 3, 2022